The global burden of chikungunya virus and the potential benefit of vaccines
Ribeiro dos Santos, G.; Jawed, F.; Mukandavire, C.; Deol, A.; Scarponi, D.; Mboera, L.; Seruyange, E.; Poirier, M. J. P.; Bosomprah, S.; Udeze, A. O.; Dellagi, K.; Hoze, N.; Chilongola, J.; Nasrallah, G. K.; Saathoff, E.; Cauchemez, S.; Salje, H.
10.1101/2024.10.24.24315872 medRxivShow abstract
The first chikungunya virus (CHIKV) vaccine has now been licensed, however, its potential to reduce disease burden remains unknown due to a poor knowledge of the underlying global burden. We use data from seroprevalence studies, observed cases and mosquito distributions to quantify the underlying burden in 190 countries and territories, and explore the potential impact of the vaccine. We estimate that 104 countries have experienced transmission, covering 2.8 billion individuals and that in epidemic settings, the mean duration between outbreaks is 6.2 years, with 8.4% of the susceptible population infected per outbreak. Globally there are 33.7 million annual infections, driven by countries in Southeast Asia, Africa and the Americas. Assuming a vaccine efficacy against disease of 70% a protection against infection of 40%, vaccinating 50% of individuals over 12 years old in places and times where the virus circulates would avert 3,718 infections, 2.8 deaths and 158 DALYs per 100,000 doses used. These findings highlight the global burden and the significant potential of the vaccine.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- The global landscape of susceptibility to orthopoxviruses: The legacy of smallpox vaccination 96%
- Estimating the impact of the w Mel release program on dengue and chikungunya incidence in Rio de Janeiro, Brazil 94%
- Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review 92%
Similar papers in this journal
- Transmission dynamics and vaccination strategies for Crimean-Congo haemorrhagic fever virus in Afghanistan: a modelling study 97%
- Spatiotemporal Variability in Dengue Transmission Intensity in Jakarta, Indonesia 95%
- Estimation of Lassa fever incidence rates in West Africa: development of a modeling framework to inform vaccine trial design 94%
Similar papers in this journal
Similar papers in this journal
- SARS-CoV-2 transmission dynamics in South Africa and epidemiological characteristics of the Omicron variant 96%
- Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries 95%
- Integrating contact tracing and whole-genome sequencing to track the elimination of dog-mediated rabies 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.